or Try an Advanced Search...

    Technical Analysis for PAR - Paradigm Biopharmaceuticals Ltd

    Grade Last Price % Change Price Change
    B 0.270 -3.57% -0.010
    PAR closed down 3.57 percent on Thursday, November 21, 2024, on 78 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    Earnings due: Nov 28
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Flat Up Up
    Historical PAR trend table...
    Date Alert Name Type % Chg
    200 DMA Support Bullish 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 200 DMA Bullish -3.57%
    Expansion Pivot Buy Setup Bullish Swing Setup -3.57%
    Pocket Pivot Bullish Swing Setup -3.57%
    Older End-of-Day Signals for PAR ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 10 hours ago
    200 DMA Support about 12 hours ago
    Fell Below 200 DMA about 12 hours ago
    Down 3% about 12 hours ago
    Down 2% about 12 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PAR Chart by TradingView
    Basic chart:

    Profile

    Paradigm Biopharmaceuticals Limited is a biopharmaceutical company focused on repurposing the drug pentosan polysulfate sodium (PPS) for the treatment of inflammation. The Company is engaged in researching and developing therapeutic products for human use. The Company is a drug repurposing company, which seeks to find new uses for old drugs. The Company has commenced the open labelled Phase II clinical trial, investigating the role of the drug PPS in treating traumatic Bone Marrow Lesions. The Company's Rhinosul has properties consisting of both histamine stabilizing and anti-inflammatory properties. The Company focuses on repurposing PPS under ZILOSUL name, as a treatment for bone marrow edema (BME) lesions following traumatic injury.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Drugs Pharmaceuticals Clinical Trial Biopharmaceutical Medical Specialties Pharmaceutical Industry Therapeutic Product Therapeutic Products Medication Organ Systems Inflammation Osteochondritis Dissecans

    Is PAR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 8 Brookside Energy And 2 Other ASX Penny Stocks To Watch
    See more PAR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.48
    52 Week Low 0.165
    Average Volume 1,305,760
    200-Day Moving Average 0.270
    50-Day Moving Average 0.220
    20-Day Moving Average 0.227
    10-Day Moving Average 0.243
    Average True Range 0.020
    RSI (14) 64.66
    ADX 24.15
    +DI 35.388
    -DI 16.642
    Chandelier Exit (Long, 3 ATRs) 0.222
    Chandelier Exit (Short, 3 ATRs) 0.254
    Upper Bollinger Bands 0.269
    Lower Bollinger Band 0.185
    Percent B (%b) 1.02
    BandWidth 36.772
    MACD Line 0.012
    MACD Signal Line 0.006
    MACD Histogram 0.0055
    Fundamentals Value
    Market Cap 61.57 Million
    Num Shares 228 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -2.48
    Price-to-Sales 0.00
    Price-to-Book 6.20
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.293
    Resistance 3 (R3) 0.293 0.287 0.289
    Resistance 2 (R2) 0.287 0.281 0.286 0.287
    Resistance 1 (R1) 0.278 0.277 0.275 0.278 0.286
    Pivot Point 0.272 0.272 0.270 0.271 0.272
    Support 1 (S1) 0.263 0.266 0.260 0.263 0.254
    Support 2 (S2) 0.257 0.262 0.256 0.253
    Support 3 (S3) 0.248 0.257 0.251
    Support 4 (S4) 0.248